M.D., Professor of Urology and Oncology, School of Medicine, Johns Hopkins University
H. Ballentine Carter, M.D., is Professor of Urology and Oncology at the Johns Hopkins University School of Medicine. He has written extensively on the diagnosis and management of prostate cancer, and chaired the American Urological Association guideline panel that made recommendations for prostate cancer diagnosis. He leads one of the largest active surveillance programs in the United States to monitor men with prostate cancer who do not need immediate treatment. Results from this program have been used to inform guidelines for the management of men with early prostate cancer. Dr. Carter has had research articles published in a number of publications, including The Journal of Urology, Urology, Cancer Research, the Journal of the American Medical Association (JAMA), the Journal of Clinical Oncology and the Journal of the National Cancer Institute.
Active Surveillance: Individualizing Prostate Cancer Care
Active surveillance (AS), an alternative to immediate curative intervention for men with favorable prostate cancer, reduces over treatment and avoids treatment related morbidity. Individualizing selection of appropriate candidates and monitoring strategies for AS represents an unmet need for the future.